Study to observe safety of CNV01 homeopathy preparation in healthy volunteers

Study of Homeopathic preparation (CVN01 nosode of COVID-19 virus) to evaluate safety in healthy volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025496

Enrollment

Registered

2020-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Healthy individuals with no major untreated diseases and normal routine laboratory parameters during the screening Able to be informed of the nature of the study and willing to give written informed consent

Exclusion criteria

Exclusion criteria: 1. Any known disease or condition (such as Cancer) which might compromise the general health or comorbid conditions 2. Subjects who have been confirmed of having COVID-19 and have been isolated for its treatment. 3. Subjects having recently suffered and recovered of COVID-19 will also be excluded from the study 4. Persons having known history of allergies, food hypersensitivity, etc. 5. Women during pregnancy, puerperium and while breast-feeding. 6. Participation in another clinical trial during the last 6 months 7. Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol

Design outcomes

Primary

Measure	Time frame
Safety measure in terms of investigations (PCR) blood parametersTimepoint: at baseline, 17th day and follow-up at 30th day	—

Secondary

Measure	Time frame
Untoward effect or adverse eventsTimepoint: At day 0, day 17	—

Countries

India

Contacts

Public ContactDr Rajesh Shah

Life Force Foundation Trust

sanjivak@gmail.com02266888888

Outcome results